<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T19:44:12Z</responseDate>
  <request identifier="oai:figshare.com:article/33870550" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33870550</identifier>
        <datestamp>2026-09-17T04:26:36Z</datestamp>
        <setSpec>category_16</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_External validation of predictive equations for determining the need for in-flight oxygen supplementation in patients with respiratory disease.pdf</dc:title>
          <dc:creator>Murielle Emma Beaupré (25001317)</dc:creator>
          <dc:creator>Gao Sheng Huang (25001320)</dc:creator>
          <dc:creator>Bruno-Pierre Dubé (5132729)</dc:creator>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>air travel</dc:subject>
          <dc:subject>desaturation</dc:subject>
          <dc:subject>fitness to fly</dc:subject>
          <dc:subject>hypoxic challenge</dc:subject>
          <dc:subject>in-flight oxygen</dc:subject>
          <dc:subject>predictive equations</dc:subject>
          <dc:description>Rationale&lt;p&gt;Patients with chronic respiratory diseases may develop clinically significant hypoxemia during commercial air travel because of reduced cabin pressure. In-flight oxygen prescription is typically guided by hypoxic challenge testing (HCT), a procedure that is time-consuming, costly, and not universally available. Several predictive equations based on sea-level physiological measurements have been proposed as alternatives. We aimed to externally validate six published predictive equations by comparing their performance with HCT in a large, heterogeneous cohort of patients with chronic respiratory diseases.&lt;/p&gt;Methods&lt;p&gt;We retrospectively analyzed all patients who underwent HCT at our center between 2016 and 2026. Sea-level arterial blood gases, pulmonary function tests, and relevant clinical data were collected. Six published predictive equations (E1–E6) were used to estimate in-flight PaO&lt;sub&gt;2&lt;/sub&gt; and compared with PaO&lt;sub&gt;2&lt;/sub&gt; measured during HCT.&lt;/p&gt;Results&lt;p&gt;A total of 177 patients were included: 39 (22%) with COPD, 64 (36%) with ILD, 34 (19%) with cystic fibrosis, and 40 (23%) with other chronic respiratory diseases. Significant correlations between predicted in-flight PaO&lt;sub&gt;2&lt;/sub&gt; and HCT PaO&lt;sub&gt;2&lt;/sub&gt; were observed (ρ = 0.48 for E1 and E2 to 0.84 for E5; all p ≤ 0.001), but diagnostic performance remained limited. Across all patients, predictive equations demonstrated high specificity (76% for E2 to 98% for E6) but inadequate sensitivity (11% for E6 to 67% for E2) for identifying patients requiring supplemental oxygen. Cohen’s κ coefficients ranged from 0.07 (95% CI, −0.06 to 0.20) for E4 to 0.43 (95% CI, 0.27–0.59) for E2. Areas under the ROC curve ranged from 0.71 (95% CI, 0.62–0.81) for E4 to 0.79 (95% CI, 0.70–0.88) for E1.&lt;/p&gt;Conclusions&lt;p&gt;In this large external validation study, currently available predictive equations demonstrated insufficient diagnostic performance to safely replace HCT for determining the need for in-flight oxygen supplementation. Although several equations showed moderate to strong agreement with measured HCT PaO&lt;sub&gt;2&lt;/sub&gt;, inadequate sensitivity resulted in clinically important misclassification of patients requiring supplemental oxygen. HCT should remain the reference standard for evaluating patients in whom the need for in-flight oxygen supplementation is uncertain.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-17T04:26:36Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fphys.2026.1946975.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_External_validation_of_predictive_equations_for_determining_the_need_for_in-flight_oxygen_supplementation_in_patients_with_respiratory_disease_pdf/33870550</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
